Foulkes A S, De Gruttola V
Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts 02115, USA.
Biometrics. 2002 Mar;58(1):145-56. doi: 10.1111/j.0006-341x.2002.00145.x.
This paper establishes a framework for understanding the complex relationships between HIV-1 genotypic markers of resistance to antiretroviral drugs and clinical measures of disease progression. A new classification scheme based on the probabilities of how new patients will respond to antiretroviral therapy given the available data is proposed as a method for distinguishing among groups of viral sequences. This approach draws from existing cluster analysis, discriminant analysis, and recursive partitioning techniques and requires a model relating genotypic characteristics to phenotypic response. A data set of 2,746 sequences and the corresponding Indinavir 50% inhibitory concentrations are described and used for illustrative purposes.